Naim Shehadeh

Naim Shehadeh

Auto-generated profile, based on publicly available information

Naim Shehadeh

Diabetes and Endocrinology Clinic, Maccabi Healthcare Services, Haifa, Israel; Institute of Endocrinology, Diabetes and Metabolism, Rambam Health Care Campus, Haifa, Israel; The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2022 in Journal of Medical Internet Research
Verified
Journal Article
Open access
YBYosefa Birati
Yosefa Birati
EYEnav Yefet
Enav Yefet
YPYuri Perlitz
Yuri Perlitz
NSNaim Shehadeh
Naim Shehadeh
SSSivan Spitzer
Sivan Spitzer
Background: The prevalence of women diagnosed with gestational diabetes mellitus (GDM) is increasing dramatically. Mobile technologies to enhance patient self-management offer many advantages for women diagnosed with GDM. However, to our knowledge, although mobile health (mHealth) and telemedicine systems for GDM management exist, evidence on their cultural and digital health literacy appropriateness levels is limited. Objective: This review aimed to search and assess the literature on mHealth and telemedicine systems designed for women diagnosed with GDM. Our assessment of these technologies focused on their cultural and digital health literacy appropriateness as well as the systems’ effectiveness in improving glycemic control and maternal and infant outcomes. Methods: We conducted a scoping review using a framework adapted from Arksey and O’Malley. Four electronic databases were searched for relevant studies: PubMed, MEDLINE (EBSCO), Web of Science, and Scopus. The databases were searched between January 2010 and January 2022. The inclusion criteria were pregnant women diagnosed with GDM, use of telemedicine for monitoring and management, and vulnerable or disadvantaged patients. We used terms related to mobile apps and telemedicine: GDM, vulnerable populations, periphery, cultural appropriateness, and digital health literacy. Studies were screened and selected independently by 2 authors. We extracted the study data on a Microsoft Excel charting table and categorized them into final themes. The results were categorized according to the cultural and digital health literacy features presented. Results: We identified 17 studies that reported on 12 telemedicine and mHealth app interventions. We assessed the studies in three domains: cultural appropriateness, digital health literacy, and maternal and infant outcomes. In the literature, we found that existing digital technologies may improve glycemic control and diabetes self-management. However, there is a lack of assessment of cultural and digital health literacy appropriateness for pregnant women diagnosed with GDM. Considerations in app design regarding cultural appropriateness were found in only 12% (2/17) of the studies, and only 25% (3/12) of the interventions scored ≥3 out of 5 in our assessment of digital health literacy. Conclusions: mHealth and telemedicine can be an effective platform to improve the clinical management of women with GDM. Although studies published on the use of mHealth and telemedicine systems exist, there is a limited body of knowledge on the digital health literacy and cultural appropriateness of the systems designed for women diagnosed with GDM. In addition, as our study was restricted to the English language, relevant studies may have been excluded. Further research is needed to evaluate, design, and implement better tailored apps regarding cultural and digital literacy appropriateness for enhancing pregnant women’s self-management as well as the effectiveness of these apps in improving maternal and infant health outcomes.

1 June 2022 in Pediatric Diabetes
Verified
Journal Article
Closed access
NLNehama Zuckerman Levin
Nehama Zuckerman Levin
MCMeidan Cohen
Meidan Cohen
MPMoshe Phillip
Moshe Phillip
ATAriel Tenenbaum
Ariel Tenenbaum
IKIlana Koren
Ilana Koren
NSNaim Shehadeh
Naim Shehadeh

25 November 2004 in Pediatric Surgery International
Verified
Journal Article
Closed access
PDF file
ISIgor Sukhotnik
Igor Sukhotnik
JMJorge Mogilner
Jorge Mogilner
RSRaanan Shamir
Raanan Shamir
NSNaim Shehadeh
Naim Shehadeh
JBJacob Bejar
Jacob Bejar
ACArnold G. Coran
Arnold G. Coran

1 January 2003 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
RSRaanan Shamir
Raanan Shamir
ANA. Nganga
A. Nganga
DBD. Berkowitz
D. Berkowitz
EDE. Diamond
E. Diamond
SLS. Lischinsky
S. Lischinsky
NSN. Shehadeh
N. Shehadeh
Bile salt-stimulated lipase (BSSL) is present in the sera of healthy humans, may affect lipoprotein structure and composition, and reduce atherogenicity of oxidized LDL-cholesterol. Our aims were to examine serum levels of BSSL in breast- and formula-fed infants, and explore the influence of BSSL on serum lipid profile and oxidative status. Infants (2-8 weeks old) were prospectively enrolled. Blood was drawn for serum levels of BSSL, total antioxidant status (TAS), and lipid profile. Serum levels of BSSL were similar in breast-fed (0.28 +/- 0.15 microg/l, n = 18) and formula-fed (0.31 +/- 0.09 microg/l, n = 15) infants, and were much lower than reported levels for adults. In breast-fed infants only, BSSL levels were correlated with LDL-cholesterol serum levels (r = -0.53, p = 0.04). Total cholesterol (119.2 +/- 34.3 mg/dl vs 97 +/- 27.2, and p = 0.05) and LDL-cholesterol serum levels (50.5 +/- 26.1 mg/dl vs 33.3 +/- 20.3, p = 0.05), were elevated in breast-fed compared with formula-fed infants, but TAS was similar in both groups (1.02 +/- 0.18 mmol/l and 0.98 +/- 0.12 mmol/l, respectively). Lack of difference in BSSL serum levels between formula- and breast-feeding, and lower BSSL levels in infants compared to adults, suggest that human milk does not contribute to BSSL serum levels.

28 July 2023 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
ANAfif Nakhleh
Afif Nakhleh
MGMirela Goldenberg-Furmanov
Mirela Goldenberg-Furmanov
RGRayna Goldstein
Rayna Goldstein
MSMordechai Shohat
Mordechai Shohat
NSNaim Shehadeh
Naim Shehadeh

14 July 2012 in Diabetes Care
Verified
Journal Article
Open access
PDF file
Itamar RazItamar Raz
Itamar Raz
SAStephanie A. Amiel
Stephanie A. Amiel
GAGeorge Alberti
George Alberti
NSNaim Shehadeh
Naim Shehadeh
SPStefano Del Prato
Stefano Del Prato
WCWilliam T. Cefalu
William T. Cefalu
The recent meeting of the International Diabetes Federation (IDF), the World Diabetes Congress 2011, took place in Dubai in December 2011. The fact that Dubai was chosen as the venue for this international congress became controversial because it was perceived by some prospective attendees that it might limit participation based on nationality or religion as a result of strict entry laws and/or fear for the security of some participants. On the other hand, the choice by the IDF was a logical one because of the fact that the Emirates and other countries in the Gulf region have an unusually high frequency of diabetes. In this region, diabetes is epidemic, with approximately 25% of the adult population affected. As a result, the physicians and Ministries of Health had a great need and strong desire to promote prevention and treatment of diabetes and its associated disorders in this region. The IDF widely publicized that the meeting was open to anyone who wanted to attend and that all would receive permits to enter the country and have their security assured. However, as the date of the meeting approached, it turned out that some Israeli passport holders, not applying via the IDF, were not able to acquire visas to enter Dubai. In addition, there were some technical difficulties on the website which made it difficult to register via the IDF Internet site. It also appears that the Israel Diabetes Association, whose members were most …